课题基金 / 基金详情

Molecular Mechanisms of UVA apotosis and carcinogenesis

Molecular Mechanisms of UVA apotosis and carcinogenesis
UVA细胞凋亡和癌变的分子机制
批准号:
6991757
负责人:
Zigang Dong
金额:
$29.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2009-06-30

项目摘要

项目成果

Zigang Dong的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):本项目拟检验的假设是ATM、磷脂酰肌醇-3激酶(PI-3激酶)、表皮生长因子受体(EGFR)、MAP激酶JNKs和p38激酶的激活在UVB诱导的信号转导和皮肤癌发生中起功能作用。因此,这些信号分子可以作为开发化学预防药物的靶点,以抑制UV/K诱导的非黑色素瘤皮肤癌。感兴趣的药物包括PI-3激酶抑制剂(LY294002和六磷酸肌醇)、EGFR抑制剂(PD153035和AG1478)、JNKs抑制剂SP600125和p38激酶抑制剂SB202190。针对这一假说的具体目的是:(1)确定UVA诱导的人和小鼠角质形成细胞中的凋亡是否通过激活ATM依赖的P53途径来介导。(2)确定JNK1和JNK2基因敲除小鼠是否能抑制UVA诱导的皮肤癌变。(3)确定在转基因小鼠的表皮中靶向表达突变的p85亚基磷脂酰肌醇-3(PI-3)激酶或显性负的p38激酶(DNp38)是否能抑制UVA诱导的皮肤癌变。(4)利用已知的针对皮肤的p38和JNK MAP激酶、EGFR、ATM和PI-3激酶的抑制剂来确定这些有效的抑制剂是否能够防止UVA诱导的SKH-1无毛小鼠皮肤癌的发生。(5)交叉验证小鼠和人UVA皮肤癌模型的化学预防靶点。该项目将侧重于UVA诱导的致癌和化学预防策略,并将与项目1密切互动,后者将侧重于UVB诱导的致癌和化学预防策略。这些临床前研究旨在为人类皮肤癌的化学预防开发新的策略,这将在项目4中进行测试。
英文摘要
DESCRIPTION (provided by applicant): The hypothesis to be tested in this project is that activation of ATM, phosphatidylinositol-3 kinase (PI-3 kinase), epidermal growth factor receptor (EGFR), MAP kinase JNKs and p38 kinases play a functional role in UVB induced signal transduction and skin carcinogenesis. Therefore these signaling molecules can be used as targets for the development of chemopreventive agents to inhibit UV/k-induced non-melanoma skin cancers. The agents of interest include PI-3 kinase inhibitors (LY294002 and inositol hexaphosphate), EGFR inhibitors (PD153035 and AG1478), JNKs inhibitor SP600125 and p38 kinase inhibitor SB202190. The Specific Aims to address the hypothesis are to: (1) Determine whether UVA-induced apoptosis is mediated by activation of an ATM-dependent p53 pathway in human and mouse keratinocytes. (2) Determine whether genetic knockout of Jnkl and Jnk2 in mice inhibits UVA-induced skin carcinogenesis. (3) Determine whether targeted expression of a mutant p85 subunit of phosphatidylinositol-3 (PI-3) kinase or a dominant negative p38 kinase (DNp38) in the epidermis of transgenic mice inhibits UVA-induced skin carcinogenesis. (4) Utilize known inhibitors of p38 and JNK MAP kinases, EGFR, ATM and PI-3 kinases targeted to the skin to determine whether these effective inhibitors will prevent UVA-induced skin carcinogenesis in an SKH-1 hairless mouse model. (5) To cross validate the targets for chemoprevention between mouse and human models of UVA skin carcinogenesis. This project will focus on UVA-induced carcinogenesis and chemoprevention strategies, and will closely interact with Project 1, which will focus on UVB-induced carcinogenesis and chemoprevention strategies. These preclinical studies are designed to lead to the development of new strategies for the chemoprevention of human skin cancers, which will be tested in Project 4.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemoprevention of colon cancer by targeting the Wnt/beta-catenin pathway
  • 批准号:
    9035378
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2015
  • 负责人:
    Zigang Dong
  • 依托单位:
Prevention of solar UV-induced skin cancer by targeting LTA4H
  • 批准号:
    9301501
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2015
  • 负责人:
    Zigang Dong
  • 依托单位:
Chemoprevention of colon cancer by targeting the Wnt/beta-catenin pathway
  • 批准号:
    9249395
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2015
  • 负责人:
    Zigang Dong
  • 依托单位:
Prevention of solar UV-induced skin cancer by targeting LTA4H
  • 批准号:
    9114539
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2015
  • 负责人:
    Zigang Dong
  • 依托单位:
海外基金